AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 285: E661-E667, 2003; doi:10.1152/ajpendo.00026.2003
0193-1849/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (16)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kondo, A.
Right arrow Articles by Togari, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kondo, A.
Right arrow Articles by Togari, A.

In vivo stimulation of sympathetic nervous system modulates osteoblastic activity in mouse calvaria

Ayami Kondo and Akifumi Togari

Department of Pharmacology, School of Dentistry, Aichi-Gakuin University, Nagoya 464-8650, Japan

Submitted 21 January 2003 ; accepted in final form 25 April 2003

Previously, we demonstrated that epinephrine induced the expression of interleukin (IL)-6 mRNA via {beta}-adrenoceptors in cultured human osteoblastic cells. IL-6 is well known to modulate bone metabolism by regulating the development and function of osteoclasts and osteoblasts. Recently, restraint stress and intracerebroventricular injection of lipopolysaccharide (LPS) have been reported to induce the expression of IL-6 mRNA in peripheral organs in mice in which expression is mediated by the activation of the sympathetic nervous system. To prove the physiological role of sympathetic nerves in bone metabolism in vivo, we examined by RT-PCR analysis the effects of restraint stress and intracerebroventricular injection of LPS on IL-6 mRNA expression in mouse calvaria. The expression of IL-6 mRNA in mouse calvaria was stimulated by either restraint stress (30 min) or intracerebroventricular injection of LPS (50 ng/mouse, 60 min). The treatment of mice with the neurotoxin 6-hydroxydopamine (6-OHDA, 100 mg · kg-1 · day-1 ip for 3 days) inhibited LPS (icv)-induced expression of IL-6 mRNA in their calvaria. The expression of IL-6 mRNA induced by the restraint stress was not influenced by 6-OHDA, which destroys noradrenergic nerve terminals. Furthermore, pretreatment with a {beta}-blocker, propranolol (15 or 25 mg/kg ip), inhibited both stress- and LPS-induced increases in the level of IL-6 mRNA, but pretreatment with an {alpha}-blocker, phentolamine (5 mg/kg sc), did not inhibit them in mouse calvaria. In addition, treatment of calvaria with isoprenaline or norepinephrine increased IL-6 synthesis in the organ culture system. These results indicate that in vivo adrenergic stimulation modulates the osteoblastic activity in mouse calvaria via noradrenergic nerve terminals.

restraint stress; intracerebroventricular injection; interleukin-6; lipopolysaccharide; calvaria; sympathetic activity; osteoblast



Address for reprint requests and other correspondence: A. Togari, Dept. of Pharmacology, School of Dentistry, Aichi-Gakuin Univ., Nagoya 464-8650, Japan (E-mail: togariaf{at}dpc.aichi-gakuin.ac.jp).




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
N. Bonnet, C. L. Benhamou, H. Beaupied, N. Laroche, L. Vico, E. Dolleans, and D. Courteix
Doping dose of salbutamol and exercise: deleterious effect on cancellous and cortical bones in adult rats
J Appl Physiol, April 1, 2007; 102(4): 1502 - 1509.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.